Main Article Content

Dr Shweta Jaiswal
Dr Ashish Kumar
Dr Sumit Saxena
Dr Kuldeep Kumar
Dr Deepshikha
Dr Deval Kumar Arora




Introduction: Vancomycin-resistant enterococcal (VRE) infections have become a significant concern in healthcare settings due to their emergence as a cause of nosocomial infections. These strains possess various resistance genes, leading to high-level inducible or low-level intrinsic resistance to vancomycin. Infections caused by VRE strains are associated with elevated mortality rates. This study aimed to characterize phenotypically and genotypically VRE strains isolated from diverse clinical samples.


Methods: One hundred enterococcal strains were isolated from various clinical samples between January 2015 and June 2016. Identification and speciation were performed using the Vitek ® 2 Compact system. Minimum inhibitory concentrations (MIC) of vancomycin and teicoplanin were determined using the E-test and agar dilution method. Genotypic characterization was conducted through multiplex polymerase chain reaction (PCR).


Results: Among the 100 Enterococcus isolates, six exhibited resistance to vancomycin by MIC testing. None of the isolates showed the VanA phenotype, while one demonstrated the VanB phenotype, speciated as E. faecalis. Three isolates displayed the VanC phenotype, identified as motile species E. gallinarum and E. casseliflavus. The three VanC phenotype isolates were positive for the vanC1 gene, indicating low-degree intrinsic vancomycin resistance. The VanB phenotype isolate positive for the vanB gene showed high-level inducible vancomycin resistance.

Conclusion: Although the VanA phenotype is commonly observed, this study did not find any VanA phenotype or genotype. These findings emphasize the need for strict protocols involving VRE screening and MIC testing.

Abstract 81 | pdf Downloads 43


1. Murray BE. The life and times of Enterococci. Clin Microbial Rev. 1990;3:46-65.
2. Quintiliani R Jr, Evers S, Courvalin P. The vanB gene confers various levels of self-transferable resistance to vancomycin in Enterococci. J Infect Dis. 1993 May;167(5):1220-3.
3. Navarro F, Courvalin P. Analysis of genes encoding D-alanine:D-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescens. Antimicrob Agents Chemother. 1994 Aug;38(8):1788-1793.
4. The Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, Wayne, PA.19087 the informational supplement. 2015;M 100-S25.
5. Udo EE, Al-Sweih N, Phillips OA, Chugh TD. Species prevalence and antibacterial resistance of Enterococci isolated in Kuwait hospitals. J Med Microbiol. 2003;52(2):163-168.
6. Mathur P, Chaudhary R, Dhawan B, Sharma N, Kumar L. Vancomycin-resistant Enterococcus bacteraemia in a lymphoma patient. Indian J Med Microbiol. 1999;17:194-5.
7. Mathur P, Kapil A, Chandra R, Sharma P, Das B. Antimicrobial resistance in Enterococcus faecalis at a tertiary care centre of northern India. Indian J Med Res. 2003;118:25-8.
8. Taneja N, Rani P, Emmanuel R, Sharma M. Significance of vancomycin-resistant enterococci from urinary specimens at a tertiary care centre in northern India. Indian J Med Res. 2004;119:72-4.
9. Kaur N, Chaudhary U, Aggarwal R, Bala K. Emergence of VRE and their antimicrobial sensitivity pattern in a tertiary care teaching hospital. J Med Biol Sci. 2009;8:26-32.
10. Centinkaya Y, Yalk P, Mayhall CG. Vancomycin-resistant Enterococci. Clin Microbiol Rev. 2000;13:686-707.
11. Praharaj I, Sujatha S, Parija SC. Phenotypic & genotypic characterization of vancomycin-resistant Enterococcus isolates from clinical specimens. Indian J Med Res. 2013;138:549-56.
12. Descheemaeker P, Leven M, Chapelle S, Lammens C. Prevalence and molecular epidemiology of glycopeptides resistant enterococci in Belgian renal dialysis. J Infect Dis. 2000;181:235-41.
13. Bekhit MM, Moussa IMI, Muharram MM, Alanazy FK, Hefni HM. Prevalence and antimicrobial resistance pattern of multidrug-resistant Enterococci isolated from clinical specimens. Indian J Med Microbiol. 2012;30(1):44-51